Jushi (JUSHF) vs. Its Competitors Head-To-Head Analysis

Jushi (OTCMKTS:JUSHF) is one of 52 public companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare Jushi to related businesses based on the strength of its institutional ownership, analyst recommendations, earnings, valuation, risk, dividends and profitability.

Analyst Recommendations

This is a summary of recent ratings for Jushi and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jushi	0	4	1	0	2.20
Jushi Competitors	242	535	859	66	2.44

As a group, “Medicinals & botanicals” companies have a potential upside of 43.46%. Given Jushi’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Jushi has less favorable growth aspects than its rivals.

Valuation & Earnings

This table compares Jushi and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Jushi	$269.45 million	-$65.10 million	-2.20
Jushi Competitors	$288.56 million	-$160.62 million	-10.45

Jushi’s rivals have higher revenue, but lower earnings than Jushi. Jushi is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Jushi and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jushi	-24.16%	-214.72%	-10.10%
Jushi Competitors	-57.31%	-62.01%	-9.70%

Insider & Institutional Ownership

21.7% of Jushi shares are held by institutional investors. Comparatively, 15.3% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.0% of Jushi shares are held by company insiders. Comparatively, 21.0% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Jushi rivals beat Jushi on 8 of the 12 factors compared.

About Jushi

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.